P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli(University of Bern), Roxana Mehran(Mount Sinai Hospital), C. Michael Gibson(Baim Institute for Clinical Research), Yangsoo Jang(Yonsei University), Sung‐Jin Hong(Inje University Sanggye Paik Hospital), Yunpeng Zhu(Shanghai Jiao Tong University), Felice Gragnano(Ospedale Sant'Anna), Peter Jüni(University of Oxford), Dominick J. Angiolillo(University of Florida), Young Bin Song(Samsung Medical Center), Dik Heg, Stephan Windecker(University of Bern), George Dangas(Mount Sinai Hospital), Shamir R. Mehta(Population Health Research Institute), Pascal Vranckx(Jessa Hospital), Kenji Andò(Kokura Memorial Hospital), Patrick W. Serruys(Erasmus MC), Hirotoshi Watanabe(Municipal Hirakata City Hospital), Hyeon‐Cheol Gwon(Samsung Medical Center), Usman Baber(Icahn School of Medicine at Mount Sinai), Joo‐Yong Hahn(Samsung Medical Center), Anna Franzone(Federico II University Hospital), Mattia Branca, Takeshi Kimura(Municipal Hirakata City Hospital), Qiang Zhao(Shanghai Jiao Tong University), Eugène McFadden(Skadden Arps Slate Meagher & Flom), Byeong‐Keuk Kim(Yonsei University)
Cited by 254
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k